Monday, February 12, 2024 12:11:36 PM
He is a Rock Star.
Why would someone like this join Know Labs?
“John Cronin is the founder and CEO of ipCapital Group, Inc., a leading global advisory company on intellectual property strategy and monetization. Cronin began his career at IBM where he was the sole inventor of breakthrough chip design technology that became the company’s most valuable patent, generating $500 million in revenue.
He went on to create the IBM Patent Factory and grew IBM’s patent portfolio from ninth to number one in the world. He played a pivotal role in increasing IBM’s patent licensing revenue from $30 million to over $2 billion a year. Cronin has been a strategic advisor and consultant to Know Labs, supporting the company’s expanding patent portfolio from 86 to 246 patents issued, pending and in process over the last twelve months, increasing its global leadership in the non-invasive blood glucose monitoring category.”
Biography
John Cronin is Chairman and CEO of ipCapital Group, Inc. (“ipCG”), an intellectual property consulting firm. Mr. Cronin founded ipCG in 1998.
Mr. Cronin and ipCG have worked with over 1,200 companies and approximately 10% of the Fortune 500 companies, hundreds of mid-size companies, and hundreds of startups and governmental laboratories. Over the years, Mr. Cronin has become a respected thought leader among executives who wish to align business issues with IP and translate strategies into actionable financial results. Mr. Cronin has inspired and trained thousands of engineers and scientists in the best practices of “how to invent.”
Mr. Cronin has authored greater than 1500 patents and applications across hundreds of technology spaces, leveraging the ipCapital Methodology."
Recent KNW News
- Know Labs to Present Clinical Research at the 2024 American Physiology Summit • Business Wire • 04/05/2024 01:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:15:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:10:40 PM
- Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study • Business Wire • 03/06/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:17:42 PM
- Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives • Business Wire • 02/29/2024 09:15:00 PM
- Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor • Business Wire • 02/27/2024 04:44:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 02:03:51 PM
- Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor • Business Wire • 02/27/2024 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:17:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:15:26 PM
- Know Labs, Inc. Reports First Quarter FY2024 Results • Business Wire • 02/14/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:23:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:22:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:20:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:19:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:18:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:17:03 PM
- Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024 • Business Wire • 02/07/2024 02:00:00 PM
- Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) • Business Wire • 01/23/2024 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/12/2024 05:15:08 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/05/2024 09:16:39 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 09:15:52 PM
- Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results • Business Wire • 12/19/2023 09:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/19/2023 09:03:19 PM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM